Comparison of serum histamine-releasing activity and clinical manifestations in chronic idiopathic urticaria.
We found increased serum histamine-releasing activity (HRA) in 27% of patients with chronic idiopathic urticaria. Patterns of clinical manifestations were similar in those with and without serum HRA, including responses to a standard treatment regimen. In HRA+ patients the degree of serum HRA generally correlated with clinical disease activity.
ACESSO AO ARTIGOhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=170261
- Histamine-releasing activity and bronchoconstricting effects of sisal
- Histamine-Releasing Factor Generated by the Interaction of Endotoxin with Hamster Serum
- Defective histamine release in chronic urticaria.
- Purification and further characterization of human mononuclear cell histamine-releasing factor.
- Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.